112 related articles for article (PubMed ID: 24906288)
21. Human amniotic mesenchymal stromal cell transplantation improves endometrial regeneration in rodent models of intrauterine adhesions.
Gan L; Duan H; Xu Q; Tang YQ; Li JJ; Sun FQ; Wang S
Cytotherapy; 2017 May; 19(5):603-616. PubMed ID: 28285950
[TBL] [Abstract][Full Text] [Related]
22. [Effect of the human amniotic membrane loaded with human amniotic mesenchymal stem cells on the skin wounds of SD rats].
Huo SZ; Shi P; Pang XN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Dec; 33(6):611-4. PubMed ID: 22509541
[TBL] [Abstract][Full Text] [Related]
23. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
[TBL] [Abstract][Full Text] [Related]
24. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.
Mitrecić D; Nicaise C; Gajović S; Pochet R
Cell Transplant; 2010; 19(5):537-48. PubMed ID: 20350352
[TBL] [Abstract][Full Text] [Related]
25. Direct comparison of the potency of human mesenchymal stem cells derived from amnion tissue, bone marrow and adipose tissue at inducing dermal fibroblast responses to cutaneous wounds.
Liu X; Wang Z; Wang R; Zhao F; Shi P; Jiang Y; Pang X
Int J Mol Med; 2013 Feb; 31(2):407-15. PubMed ID: 23228965
[TBL] [Abstract][Full Text] [Related]
26. Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats.
Roh DH; Seo MS; Choi HS; Park SB; Han HJ; Beitz AJ; Kang KS; Lee JH
Cell Transplant; 2013; 22(9):1577-90. PubMed ID: 23294734
[TBL] [Abstract][Full Text] [Related]
27. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
[TBL] [Abstract][Full Text] [Related]
28. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
Franz CK; Federici T; Yang J; Backus C; Oh SS; Teng Q; Carlton E; Bishop KM; Gasmi M; Bartus RT; Feldman EL; Boulis NM
Neurobiol Dis; 2009 Mar; 33(3):473-81. PubMed ID: 19135533
[TBL] [Abstract][Full Text] [Related]
29. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
30. [Effect of transplantation of wild-type bone marrow stem cells in mouse model of familial amyotrophic lateral sclerosis].
Huang H; Zhang C; Zhao CP; Yao XL; Xi J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):562-6. PubMed ID: 16995314
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?
Allers C; Jones JA; Lasala GP; Minguell JJ
Regen Med; 2014; 9(5):637-47. PubMed ID: 25372079
[TBL] [Abstract][Full Text] [Related]
33. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies.
Phermthai T; Thongbopit S; Pokathikorn P; Wichitwiengrat S; Julavijitphong S; Tirawanchai N
Cytotherapy; 2017 Aug; 19(8):990-1001. PubMed ID: 28566211
[TBL] [Abstract][Full Text] [Related]
34. Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis.
Magota H; Sasaki M; Kataoka-Sasaki Y; Oka S; Ukai R; Kiyose R; Onodera R; Kocsis JD; Honmou O
Mol Brain; 2021 May; 14(1):76. PubMed ID: 33962678
[TBL] [Abstract][Full Text] [Related]
35. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS.
Garbuzova-Davis S; Rodrigues MC; Mirtyl S; Turner S; Mitha S; Sodhi J; Suthakaran S; Eve DJ; Sanberg CD; Kuzmin-Nichols N; Sanberg PR
PLoS One; 2012; 7(2):e31254. PubMed ID: 22319620
[TBL] [Abstract][Full Text] [Related]
36. Different therapeutic effects of cells derived from human amniotic membrane on premature ovarian aging depend on distinct cellular biological characteristics.
Ding C; Li H; Wang Y; Wang F; Wu H; Chen R; Lv J; Wang W; Huang B
Stem Cell Res Ther; 2017 Jul; 8(1):173. PubMed ID: 28750654
[TBL] [Abstract][Full Text] [Related]
37. Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites.
Pischiutta F; Brunelli L; Romele P; Silini A; Sammali E; Paracchini L; Marchini S; Talamini L; Bigini P; Boncoraglio GB; Pastorelli R; De Simoni MG; Parolini O; Zanier ER
Crit Care Med; 2016 Nov; 44(11):e1118-e1131. PubMed ID: 27441900
[TBL] [Abstract][Full Text] [Related]
38. Placental stem cells.
Antoniadou E; David AL
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():13-29. PubMed ID: 26547389
[TBL] [Abstract][Full Text] [Related]
39. Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiation.
Shakhbazau A; Potapnev M
Cytotherapy; 2016 Oct; 18(10):1245-55. PubMed ID: 27426933
[TBL] [Abstract][Full Text] [Related]
40. The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms.
Tang BL
Rev Neurosci; 2017 Oct; 28(7):725-738. PubMed ID: 28599400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
